New Jersey-based Seqirus today announced new real-world evidence supporting the relative effectiveness of FLUAD® , its adjuvanted trivalent vaccine (aTIV), compared with standard-dose, non-adjuvanted trivalent influenza vaccine and standard-dose quadrivalent influenza vaccine in reducing influenza-related outcomes... READ →
Precision Vaccinations/ December 7th, 2021
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Dec 7 • 4:16 pm CST
Dec 7 • 2:39 pm CST
The Texas Department of State Health Services (DSHS) announced today it is launching a new COVID-19 therapeutic infusion center in El Paso. This innovative treatment is available at no cost to the patient. COVID-19 antibody infusion... READ →
Dec 7 • 1:14 pm CST
Basel-based Roche announced that the European Commission (EC) had extended the marketing authorization for Actemra® / RoActemra® today to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or... READ →
Dec 7 • 9:38 am CST
England-based Medicago and GlaxoSmithKline (GSK) today announced positive results from the global Phase 3 placebo-controlled efficacy study of Medicago's plant-based COVID-19 vaccine candidate in combination with GSK's pandemic adjuvant, conducted across six countries. The overall vaccine... READ →
Dec 7 • 5:34 am CST
California-based Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an update to non-peer-reviewed preclinical data demonstrating that sotrovimab, an investigational monoclonal antibody, retains in vitro activity against the known Omicron spike protein, the new SARS-CoV-2 variant... READ →
For more articles, try our search.